Patient with diffuse mesangial and endocapillary proliferative glomerulonephritis with hypocomplementemia and elevated anti-streptolysin 0 treated with prednisolone, angiotensin-converting enzyme inhibitor, and angiotensin II receptor antagonist

Clinical and Experimental Nephrology

Volumn 7, Issue 4, 2003, Pages 290-295

  Ito, Satoshi ^a   Kuriyama, Hideyuki ^a   Iino, Noriaki ^a   Iguchi, Seitaro ^a   Shimada, Hisaki ^a   Ueno, Mitsuhiro ^a   Narita, Ichiei ^a   Nakano, Masaaki ^b   Nishi, Shin Ichi ^b   Karasawa, Ryo ^c   Gejyo, Fumitake ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c Department of Medicine   (Japan)

Author keywords

Angiotensin II receptor antagonist; Angiotensin converting enzyme inhibitor; Antistreptolysin O; Hypocomplementemia; Mesangial and endocapillary proliferative glomerulonephritis; Systemic lupus erythematosus

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINUCLEAR ANTIBODY; ANTISTREPTOLYSIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOSARTAN; PREDNISOLONE; QUINAPRIL;

ADULT; ARTICLE; CAPILLARY WALL; CASE REPORT; CELL PROLIFERATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; ELECTRON MICROSCOPY; FEMALE; HEMATURIA; HUMAN; HUMAN TISSUE; HYPOCOMPLEMENTEMIA; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTOPENIA; MESANGIUM; MESANGIUM CELL; MICROSCOPY; MICROTUBULE; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS; COMPLEMENT SYSTEM PROTEINS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; PREDNISOLONE; RECEPTORS, ANGIOTENSIN; STREPTOLYSINS;

EID: 9144252560     PISSN: 13421751     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10157-003-0244-0     Document Type: Article

References (17)

1. Falk RJ, Jennet JC, Nachman PH. Primary glomerular diseases. In: Brenner BM, Rector FV Jr, editors. The kidney. 6th Ed. Philadelphia: WB Saunders; 2000. p. 1263-349.
2. Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
3. Hochenberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 1997;40:1725.
4. Hebert LA, Cosio FG, Neff JC. Diagnostic significance of hypocomplementemia. Kidney Int 1991;39:811-21.
5. Matsell DG, Roy S III, Tamerius JD, Morrow PR, Kolb WP, Wyatt RJ. Plasma terminal complement complexes in acute poststreptococcal glomerulonephritis. Am J Kidney Dis 1991;17:311-6.
6. Kaplan EL, Vernier RL. Progressive nephritis after strep infection questioned. Am J Med 1978;64:910-1.
7. Appel GB, Radhakrishnan J, D'Agati V. Secondary glomerular diseases. In: Brenner BM, Rector FV Jr, editors. The kidney. 6th Ed. Philadelphia: WB Saunders; 2000. p. 1350-448.
8. Hurd ER, Eigenbrodt E, Worthen H, Strunk SS, Ziff M. Glomerular cytoplasmic tubular structures in renal biopsies of patients with systemic lupus erythematosus and other diseases. Arthritis Rheum 1971;14:539-50.
9. Histopathology of the glomerulus under high power magnification. In: Zollinger HU, Mihatsch MJ, editors. Renal pathology in biopsy. Berlin Heidelberg New York Tokyo: Springer-Verlag; 1974. p. 54-115.
10. Nakazawa T, Tomosugi N, Sakamoto K, Asaka M, Yuri T, Ishikawa I, Kitagawa S. Acute glomerulonephritis after human parvovirus B19 infection. Am J Kidney Dis 2000;35:E31.1-8.
11. Komatsuda A, Ohtani H, Nimura T, Yamaguchi A, Wakui H, Imai H, et al. Endocapillary proliferative glomerulonephritis in a patient with parvovirus B 19 infection. Am J Kidney Dis 2000;36:851-4.
12. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibitor on diabetic nephropathy. N Engl J Med 1993;329:1456-62.
13. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999;31:359-64.
14. Russo D, Pisani A, Balletta MM, De Nicola L, Savino FA, Andreucci M. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis 1999;33:851-6.
15. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997;51:2-15.
16. Gansevoort RT, de Zeeuw D, de Jong PE. Is the antiproteinuric effect of ACE inhibition mediated by interference in the reninangiotensin system? Kidney Int 1994;45:861-7.
17. Nakano M, Ueno M, Hasegawa H, Watanabe T, Kuroda T, Ito S, et al. Renal haemodynamic characteristics in patients with lupus nephritis. Ann Rheum Dis 1998;57:226-30.